Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-12

Clinical Trial Update: Study of Optimal Replacement of Thyroxine in the Elderly [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on optimal thyroxine (levothyroxine) replacement in elderly patients with hypothyroidism; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)

Snippet

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Hypothyroidism | Phase 4 | Status: COMPLETED